Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment - PubMed

Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment

M Sharma et al. Life Sci. 2001.

Abstract

Recent reports suggest the involvement of free radicals in the pathophysiology of Alzheimer's disease [AD]. Streptozotocin [STZ] injection in the brain is known to cause cognitive impairment in rats and is likened to sporadic AD in humans. Though STZ is known to cause impairment in glucose and energy metabolism, it is not known whether this is associated with free radical generation. The present study was designed to investigate if the changes in learning and memory by intracerebroventricular administration of STZ are associated with changes in the markers of oxidative stress. Adult male Wistar rats [330-340 g] were injected with intracerebroventricular STZ [3 mg/kg] bilaterally stereotaxically under ketamine anesthesia [70 mg/kg]. The rats were treated with STZ twice, on day 1 and on day 3. The learning and memory behavior was analyzed using passive avoidance paradigms, elevated plus maze and the closed field activity test while the parameters of oxidative stress assessed were malondialdehyde [MDA] and glutathione. The behavioral tests were performed on day 17, 18 and 19. The rats developed significant deficits in learning, memory and cognitive behavior, indicated by deficits in passive avoidance paradigm and elevated plus maze as compared to sham rats. On day 21, the rats were sacrificed under ether anesthesia and the brains were analyzed for biochemical studies. There was a development of oxidative stress in the brain as indicated by significant elevations in malondialdehyde [MDA] levels and decreased levels of glutathione. The study demonstrates that intracerebroventricular STZ may be appropriate model for investigations of antioxidants as potential treatment in Alzheimer's dementia.

Similar articles

• Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats.

  Veerendra Kumar MH, Gupta YK. Veerendra Kumar MH, et al. Pharmacol Biochem Behav. 2002 Oct;73(3):565-71. doi: 10.1016/s0091-3057(02)00838-9. Pharmacol Biochem Behav. 2002. PMID: 12151031

• Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats.

  Tiwari V, Kuhad A, Bishnoi M, Chopra K. Tiwari V, et al. Pharmacol Biochem Behav. 2009 Aug;93(2):183-9. doi: 10.1016/j.pbb.2009.05.009. Epub 2009 May 21. Pharmacol Biochem Behav. 2009. PMID: 19464315

• Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats.

  Sharma M, Gupta YK. Sharma M, et al. Pharmacol Biochem Behav. 2001 Oct-Nov;70(2-3):325-31. doi: 10.1016/s0091-3057(01)00611-6. Pharmacol Biochem Behav. 2001. PMID: 11701204

• Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

  Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Correia SC, et al. Ageing Res Rev. 2011 Apr;10(2):264-73. doi: 10.1016/j.arr.2011.01.001. Epub 2011 Jan 22. Ageing Res Rev. 2011. PMID: 21262392 Free PMC article. Review.

Cited by

• Protective Effects of Repetitive Transcranial Magnetic Stimulation Against Streptozotocin-Induced Alzheimer's Disease.

  Kim SK, Lee GY, Kim SK, Kwon YJ, Seo EB, Lee H, Lee SH, Kim SJ, Lee S, Ye SK. Kim SK, et al. Mol Neurobiol. 2024 Mar;61(3):1687-1703. doi: 10.1007/s12035-023-03573-8. Epub 2023 Sep 27. Mol Neurobiol. 2024. PMID: 37755583 Free PMC article.

• Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice.

  Ryu Y, Kim YJ, Kim YY, Kim J, Kim SW, Kim H, Ku SY. Ryu Y, et al. Int J Mol Sci. 2021 Jan 28;22(3):1299. doi: 10.3390/ijms22031299. Int J Mol Sci. 2021. PMID: 33525535 Free PMC article.

• Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats.

  Yin QQ, Pei JJ, Xu S, Luo DZ, Dong SQ, Sun MH, You L, Sun ZJ, Liu XP. Yin QQ, et al. PLoS One. 2013;8(3):e59313. doi: 10.1371/journal.pone.0059313. Epub 2013 Mar 20. PLoS One. 2013. PMID: 23527159 Free PMC article.

• Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways.

  El-Nashar HAS, Abbas H, Zewail M, Noureldin MH, Ali MM, Shamaa MM, Khattab MA, Ibrahim N. El-Nashar HAS, et al. Pharmaceuticals (Basel). 2022 Sep 28;15(10):1202. doi: 10.3390/ph15101202. Pharmaceuticals (Basel). 2022. PMID: 36297313 Free PMC article.

MeSH terms

Substances